These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37776221)

  • 1. Severe Fontan-Associated Liver Disease and Its Association With Mortality.
    Guerrero-Chalela CE; Therrien J; Grossman Y; Guo L; Liu A; Marelli A
    J Am Heart Assoc; 2023 Oct; 12(19):e024034. PubMed ID: 37776221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Fontan-associated Liver Disease and Ethnic Disparities in Long-term Survivors of the Fontan Procedure: A Population-based Study.
    Emamaullee J; Martin S; Goldbeck C; Rocque B; Barbetta A; Kohli R; Starnes V
    Ann Surg; 2022 Sep; 276(3):482-490. PubMed ID: 35766375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation.
    Lewis MJ; Reardon LC; Aboulhosn J; Haeffele C; Chen S; Kim Y; Fuller S; Forbess L; Alshawabkeh L; Urey MA; Book WM; Rodriguez F; Menachem JN; Clark DE; Valente AM; Carazo M; Egbe A; Connolly HM; Krieger EV; Angiulo J; Cedars A; Ko J; Jacobsen RM; Earing MG; Cramer JW; Ermis P; Broda C; Nugaeva N; Ross H; Awerbach JD; Krasuski RA; Rosenbaum M
    J Am Coll Cardiol; 2023 Jun; 81(22):2149-2160. PubMed ID: 37257950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Mid-Term Liver Disease After the Fontan Procedure.
    Oka N; Miyamoto T; Tomoyasu T; Hayashi H; Miyaji K
    Int Heart J; 2020 Sep; 61(5):979-983. PubMed ID: 32921662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver Disease.
    Kim MH; Nguyen A; Lo M; Kumar SR; Bucuvalas J; Glynn EF; Hoffman MA; Fischer R; Emamaullee J
    Transplantation; 2021 Jan; 105(1):18-22. PubMed ID: 32639398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research priorities in Fontan-associated liver disease.
    Khan S; Aziz H; Emamaullee J
    Curr Opin Organ Transplant; 2020 Oct; 25(5):489-495. PubMed ID: 32833705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of Fontan Associated Liver Disease in Childhood and Adolescence.
    Hansen JH; Khodami JK; Moritz JD; Rinne K; Voges I; Scheewe J; Kramer HH; Uebing A
    Semin Thorac Cardiovasc Surg; 2022; 34(2):642-650. PubMed ID: 33979666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fontan-Associated Liver Disease: Proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC.
    Daniels CJ; Bradley EA; Landzberg MJ; Aboulhosn J; Beekman RH; Book W; Gurvitz M; John A; John B; Marelli A; Marino BS; Minich LL; Poterucha JJ; Rand EB; Veldtman GR
    J Am Coll Cardiol; 2017 Dec; 70(25):3173-3194. PubMed ID: 29268929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing hepatic impairment in Fontan-associated liver disease using the HepQuant SHUNT test.
    Lemmer A; VanWagner L; Gasanova Z; Helmke S; Everson GT; Ganger D
    Congenit Heart Dis; 2019 Nov; 14(6):978-986. PubMed ID: 31369200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associated Factors of Liver Disease After Fontan Operation in Relation to Ultrasound Liver Elastography.
    Sethasathien S; Silvilairat S; Sittiwangkul R; Makonkawkeyoon K; Pongprot Y
    Pediatr Cardiol; 2020 Dec; 41(8):1639-1644. PubMed ID: 32740670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of liver cirrhosis and hepatocellular carcinoma among perioperative survivors of the Fontan operation.
    Inuzuka R; Nii M; Inai K; Shimada E; Shinohara T; Kogiso T; Ono H; Otsuki SI; Kurita Y; Takeda A; Hirono K; Takei K; Yasukohchi S; Yoshikawa T; Furutani Y; Shinozaki T; Matsuyama Y; Senzaki H; Tokushige K; Nakanishi T
    Heart; 2023 Jan; 109(4):276-282. PubMed ID: 35768191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fontan-associated liver disease after heart transplant.
    Griffiths ER; Lambert LM; Ou Z; Shaaban A; Rezvani M; Carlo WF; Schumacher KR; DiPaola F; O'Connor MJ; Nandi D; Zangwill S; McCulloch MA; Friedland-Little JM; West SC; Lee TM; Alejos JC; Chen S; Molina KM
    Pediatr Transplant; 2023 Mar; 27(2):e14435. PubMed ID: 36380561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for Fontan-associated hepatocellular carcinoma.
    Kogiso T; Sagawa T; Taniai M; Shimada E; Inai K; Shinohara T; Tokushige K
    PLoS One; 2022; 17(6):e0270230. PubMed ID: 35714161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of Fontan-associated liver disease.
    Dillman JR; Trout AT; Alsaied T; Gupta A; Lubert AM
    Pediatr Radiol; 2020 Oct; 50(11):1528-1541. PubMed ID: 32809067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fontan-Associated Liver Disease: Evidence for Early Surveillance of Liver Health in Pediatric Fontan Patients.
    Rathgeber SL; Harris KC
    Can J Cardiol; 2019 Feb; 35(2):217-220. PubMed ID: 30760429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of Fontan-Associated Liver Disease Correlates with Fontan Hemodynamics.
    Schleiger A; Salzmann M; Kramer P; Danne F; Schubert S; Bassir C; Müller T; Müller HP; Berger F; Ovroutski S
    Pediatr Cardiol; 2020 Apr; 41(4):736-746. PubMed ID: 32006084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biventricular repair versus Fontan completion for patients with d- or l-transposition of the great arteries with ventricular septal defect and left ventricular outflow tract obstruction.
    Sun J; Brizard C; Winlaw D; Alphonso N; d'Udekem Y; Eastaugh L; Marathe S; Bell D; Ayer J
    J Thorac Cardiovasc Surg; 2019 Oct; 158(4):1158-1167.e1. PubMed ID: 31301903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular liver biopsy for Fontan associated liver disease surveillance: Technique, outcomes and hemodynamic correlation.
    Borquez AA; Silva-Sepulveda J; Lee JW; Vavinskaya V; Vodkin I; El-Sabrout H; Towbin R; Perry JC; Moore JW; El-Said HG
    Int J Cardiol; 2021 Apr; 328():83-88. PubMed ID: 33278420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fate of the liver in the survivors of adult heart transplant for a failing Fontan circulation.
    Broda CR; Alonso-Gonzalez R; Ghanekar A; Gulamhusein A; McDonald M; Luk A; Kobulnik J; Billia F; Heggie J; Jariani M; Honjo O; Barron D; Hickey E; Roche SL
    J Heart Lung Transplant; 2022 Mar; 41(3):283-286. PubMed ID: 34953719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive biomarkers of Fontan-associated liver disease.
    Emamaullee J; Khan S; Weaver C; Goldbeck C; Yanni G; Kohli R; Genyk Y; Zhou S; Shillingford N; Sullivan PM; Takao C; Detterich J; Kantor PF; Cleveland JD; Herrington C; Ram Kumar S; Starnes V; Badran S; Patel ND
    JHEP Rep; 2021 Dec; 3(6):100362. PubMed ID: 34693238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.